THE MCMANUS GROUP for NOVARTIS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
TAX-legislation and regulations affecting taxation of pharmaceutical products, including research and development and orphan drug tax credits. HCR-- legislation and regulations affecting pharmaceutical coverage and payments in federal programs MMM -- Pharmaceutical coverage and access in Parts A, B, C, and D
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS New | Staff Director W&M; LA, Rep. Bill Thomas |
| BARRETT THORNHILL New | — |
Medicare/Medicaid MMM
TAX-legislation and regulations affecting taxation of pharmaceutical products, including research and development and orphan drug tax credits. HCR-- legislation and regulations affecting pharmaceutical coverage and payments in federal programs MMM -- Pharmaceutical coverage and access in Parts A, B, C, and D
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS New | Staff Director W&M; LA, Rep. Bill Thomas |
| BARRETT THORNHILL New | — |
Taxation/Internal Revenue Code TAX
TAX-legislation and regulations affecting taxation of pharmaceutical products, including research and development and orphan drug tax credits. HCR-- legislation and regulations affecting pharmaceutical coverage and payments in federal programs MMM -- Pharmaceutical coverage and access in Parts A, B, C, and D
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS New | Staff Director W&M; LA, Rep. Bill Thomas |
| BARRETT THORNHILL New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVARTIS AG | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.